Literature DB >> 6524453

The Kockum study: twenty-two-year follow-up. Coronary heart disease in a population in the south of Sweden.

B Persson, B W Johansson.   

Abstract

The Kockum study of risk factors for coronary heart disease (CHD) consists of 464 individuals, one third white collar workers, one third heavy workers and one third well trained firemen, all of whom have now been followed for 22 years. Important risk factors for CHD seem to be heredity, smoking, stress, lack of physical activity, diabetes mellitus hypertension, high body weight, ECG abnormalities, hypercholesterolemia, hypertriglyceridemia and baldness. In addition to the common risk factors, baldness seems to be of importance. A high cholesterol value predisposes for an increased death rate not only due to CHD but also to malignant disease. A Cox analysis shows a markedly decreased life expectancy in multirisk factor patients caused not only by CHD but also by cancer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6524453

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

1.  Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up.

Authors:  Dhananjay Vaidya; Lisa R Yanek; Taryn F Moy; Thomas A Pearson; Lewis C Becker; Diane M Becker
Journal:  Am J Cardiol       Date:  2007-08-16       Impact factor: 2.778

2.  Assessing possible hazards of reducing serum cholesterol.

Authors:  M R Law; S G Thompson; N J Wald
Journal:  BMJ       Date:  1994-02-05

3.  Total cholesterol concentration and mortality at a relatively young age: do men and women differ?

Authors:  W M Monique Verschuren; D Kromhout
Journal:  BMJ       Date:  1995-09-23

4.  Association of male pattern baldness with angiographic coronary artery disease severity and collateral development.

Authors:  I Sari; K Aykent; V Davutoglu; M Yuce; O Ozer; M Kaplan; H Alici; S Ercan; M Sunbul; K Tigen
Journal:  Neth Heart J       Date:  2015-04-01       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.